Ultragenyx Pharmaceutical Gross Profit (TTM) Insights

Ultragenyx Pharmaceutical Inc (RARE)

41.90 -0.71 (-1.67%) USD | NASDAQ | May 17, 16:00

41.90 0.00 (0.00%) After-Hours: 20:00

Gross Profit (TTM) Chart

Historical Gross Profit (TTM) Data

View and export this data back to 2018. Upgrade now.

Date	Value
March 31, 2024	392.10M
December 31, 2023	389.04M
September 30, 2023	371.73M
June 30, 2023	366.74M
March 31, 2023	349.41M
December 31, 2022	335.01M
September 30, 2022	316.86M
June 30, 2022	312.26M
March 31, 2022	315.03M
December 31, 2021	335.40M
September 30, 2021	341.58M
June 30, 2021	343.23M

Date	Value
March 31, 2021	319.30M
December 31, 2020	264.90M
September 30, 2020	209.33M
June 30, 2020	153.32M
March 31, 2020	116.80M
December 31, 2019	94.71M
September 30, 2019	79.97M
June 30, 2019	68.35M
March 31, 2019	57.62M
December 31, 2018	50.35M
September 30, 2018	37.01M
June 30, 2018	25.72M

Gross Profit Definition

Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.

Read full definition.

Gross Profit (TTM) Range, Past 5 Years

68.35M

Minimum

Jun 2019

392.10M

Maximum

Mar 2024

273.75M

Average

318.08M

Median

Gross Profit (TTM) Benchmarks